Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
“Mini-mental state”
1975 • 82,784 citations
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 • 14,850 citations
Vascular dementia
1993 • 4,707 citations
A new rating scale for Alzheimer's disease
1984 • 3,948 citations
J Neuropsychiatry Clin Neurosci
1992 • 3,756 citations
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
1997 • 1,970 citations
The Neuropsychiatric Inventory
1997 • 1,874 citations
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
1997 • 1,509 citations
A 5-month, randomized, placebo-controlled trial of galantamine in AD
2000 • 911 citations
Galantamine in AD
2000 • 864 citations
Development of a Functional Measure for Persons With Alzheimer’s Disease: The Disability Assessment for Dementia
1999 • 850 citations
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
2000 • 689 citations
Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change
1997 • 620 citations
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
2000 • 609 citations
Overlap Between Pathology of Alzheimer Disease and Vascular Dementia
1999 • 467 citations
Prevalence and outcomes of vascular cognitive impairment
2000 • 382 citations
Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)
1997 • 310 citations
Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia
1997 • 245 citations
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
1996 • 243 citations
Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
2000 • 216 citations
Vascular Factors and Alzheimer Disease
1999 • 175 citations
An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors
2000 • 158 citations
Rethinking Vascular Dementia (Part 1 of 2)
1993 • 136 citations
Subtypes of Vascular Dementia
1999 • 69 citations
Cerebrovascular Dementia
1999 • 67 citations
Use of Donepezil for Vascular Dementia
1999 • 55 citations
Diagnosis of vascular dementia and Alzheimer's disease.
2001 • 38 citations
Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease.
2001 • 14 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database